Search results for: Maria Lowe
Filter search results
OHE’s submission for the DHSC’s next 10 years of planning
9 December 2024
…societal returns) and that it is likely to be good for the economy (e.g. as preventable multimorbidity leads to lower work-force participation pre-retirement) However, current prevention (including public health and…
Advancing Rare Disease Care: Challenges and Key Issues
28 February 2025
…drugs routed to the standard single technology appraisal (STA) – recommendation rates are lower than those routed to HST (71% versus 97%), which potentially relates to the lower threshold applied…
GLP-1 Receptor Agonists: Shifting Obesity Management
12 May 2025
…population with obesity. For example, some people may prefer oral formulations over injectables due to comfort or convenience, even if the efficacy is slightly lower. Others may tolerate more severe…
Prevention in the NHS 10 Year Health Plan: Promise, limits, and the path forward
17 September 2025
…affluent areas. To reduce this, interventions must be actively targeted at the communities that need them most. The Plan’s commitment to establishing Neighbourhood Health Centers first in areas with lowest…
New OHE research finds productivity losses from respiratory infections cost UK businesses £44 billion per year
16 December 2024
Productivity losses from respiratory infections cost UK businesses £44 billion per year, or £852 per employee. Presenteeism (working but with lower productivity) due to respiratory infections costs businesses more than absenteeism, making up about 55% of the…
Europe’s pharmaceutical policy choices – And what the United States stands to learn
18 March 2026
…we adopt European prices, we’re dealing with their threshold,” Garrison said. “That’s the real problem.” For U.S. policymakers, therefore, the question is not simply whether European prices are lower. It…
The Impact of Price-cap Regulations on Entry and Exit by Generic Pharmaceutical Firms in Canada
23 February 2015, 12:00am
…the early 1990s adopted progressively lower price-caps. Dr. Aslam Anis will report the results of studies describing the impact of the latest wave of price-caps instituted in Canadian provinces…
Biosimilars: Modelling the Evolution of the Market
16 June 2010
…not list price, and recognising the critical role of PSY data. In particular, the OHE model (1) predicts less rapid erosion of price in the short term and (2) suggests lower…
OHE Lunchtime Seminar on 23 February 2015: The Impact of Price-cap Regulations on Entry and Exit by Generic Pharmaceutical Firms in Canada
22 January 2015
…generic price-cap regulations in relation to the price of the brand-name drug, and has since the early 1990s adopted progressively lower price-caps. Dr. Aslam Anis will report the results…